stockrowAMNEAL PHARMACEUTICALS, INC. (AMRX) vs Elanco Animal Health Incorporated (ELAN)
- AMNEAL PHARMACEUTICALS, INC. AMRX 19.41 −2.71%
- Elanco Animal Health Incorporated ELAN 23.74 −6.20%
AMNEAL PHARMACEUTICALS, INC. and Elanco Animal Health Incorporated are both Drug Manufacturers Specialty & Generic companies. Elanco Animal Health Incorporated is the larger, with a market value of $11.8B against $6.8B — 1.7× the size. Elanco Animal Health Incorporated has negative trailing earnings, so its P/E is not meaningful; AMNEAL PHARMACEUTICALS, INC. trades at 36.9×. Elanco Animal Health Incorporated grew revenue faster over the last twelve months: 12.0% against 8.88%. AMNEAL PHARMACEUTICALS, INC. has the higher net margin (4.17% vs −3.96%) and the higher return on invested capital (8.45% vs 0.51%). Across the 20 metrics below, AMNEAL PHARMACEUTICALS, INC. leads on 11 and Elanco Animal Health Incorporated on 9.
Valuation
Profitability
| Metric | AMRX | ELAN | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 40.24% | 55.36% | 53.51% |
| Operating margin | 14.99% | 1.61% | 0.00% |
| Net margin | 4.17% | (3.96%) | (2.45%) |
| Free cash flow margin | (1.89%) | 7.55% | 0.00% |
| Return on equity | (53,107.17%) | (2.98%) | (0.80%) |
| Return on assets | 3.01% | (1.46%) | (1.67%) |
| Return on invested capital | 8.45% | 0.51% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack